ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,115, issued on Dec. 2, was assigned to EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE (Blacksburg, Va.).

"Biased NMDA receptor modulators and uses thereof" was invented by Blaise Mathias Costa (Blacksburg, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds that can be capable of modulating an N-methyl-D-aspartate (NMDA) receptor. In some embodiments, the compound(s) can be a biased modulator of an NMDA receptor. In some embodiments, the compound(s) can be a biased allosteric modulator of an NMDA receptor. Also described herein are methods of treating an NMDA-mediated disease by administering one or more of the compounds des...